HOME >> MEDICINE >> NEWS
Chemotherapy options improve for patients with advanced colorectal cancer

For the first time, researchers have shown that a chemotherapy regimen of capecitabine plus oxaliplatin (CAPOX) is as safe and effective as infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) in the first-line treatment of metastatic colorectal carcinoma (MCRC). The findings are reported today at the 2nd ESMO Scientific & Educational Conference (ESEC) in Budapest, Hungary.

"We conducted this phase III study because the combination of oral capecitabine and oxaliplatin showed promising effects in different phase II studies. The idea of this study was to look whether CAPOX can replace the standard treatment of iv. 5-FU/folinic acid in patients with MCRC", said lead author Dr. Hendrik-Tobias Arkenau, from Clinic Bremen East in Germany.

From 2002 to 2004, the authors randomly assigned 476 patients who had not undergone previous chemotherapy to receive either FUFOX (5-fluorouracil (5-FU) 2000mg/m 24h infusion, folinic acid 500mg/m, oxaliplatin 50mg/m d1,8,15,22; q5 wks) or CAPOX (capecitabine 1000mg/m bid d1-14, oxaliplatin 70mg/m d1 and 8; q3 wks).

So far, based on an analysis of 2541 treatment cycles (1026 FUFOX, 1515 CAPOX), both regimens are comparably toxic and showed similar response rates (ITT-RR: 50% FUFOX and 47% CAPOX, p=NS).

Median length of time without progression of disease was 34.7 weeks in the FUFOX arm and 30.3 weeks in the CAPOX arm, respectively, a difference that was not statistically different (p=0.1), the authors found. Additionally, both treatment arms showed similar overall survival, FUFOX 74.9 weeks and CAPOX 70.9 weeks, p=0.72.

The authors conclude that CAPOX shows comparable efficacy and toxicity profiles compared to the FUFOX regimen in patients chemonaive MCRC.

"This study is important for patients because the CAPOX regimen is more convenient to administer. Patients will appreciate needing to come only twice in three weeks as outpatients to receive the 2 hourly oxaliplatin dose. Esp
'"/>

Contact: Gracemarie Bricalli
gracemarie@esmo.org
41-91-973-1911
European Society for Medical Oncology
6-Jun-2005


Page: 1 2

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Chemotherapy may enhance the effectiveness of brain tumor vaccines
3. Chemotherapy more effective when given before breast cancer surgery
4. Chemotherapy temporarily affects the structures of the human brain
5. Chemotherapy gel may fight breast cancer and reduce breast deformity
6. Chemotherapy given directly to the liver improves survival for patients with colorectal cancer
7. Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
8. Chemotherapy errors rare, but have potential for serious consequences
9. Chemotherapy for brain tumors is boosted after vaccine targets resistance-related antigen
10. Asthma study shows patients have more options to control disease
11. Study sheds light on medication treatment options for bipolar disorder

Post Your Comments:
(Date:3/30/2015)... Angeles, CA (PRWEB) March 30, 2015 On ... New Ways to Blast Away Fat,” details six new treatment ... treatments require injections and one is a topical product. The ... UltraShape and Liposonix ) or freezing cold ( ... are so many options now available to us to permanently ...
(Date:3/30/2015)... 2015 A key protein previously implicated ... an important role in the response to viral infection, ... Icahn School of Medicine at Mount Sinai published today ... been associated with inflammation, part of the body’s response ... home in to attack invaders like bacteria and viruses, ...
(Date:3/30/2015)... 2015 Vancouver personal injury lawyer firm, ... of cases taken up by the firm are settled ... lawyers help protect the interests of their clients without ... The announcement comes across as an achievement for the ... provide convenience to their client, without compromising their rights. ...
(Date:3/30/2015)... Follow us on LinkedIn – ... establish chronic pain rehabilitation centers are driving demand for ... poised to benefit from the rise in acute and ... chronic health conditions such as Cancer, degenerative diseases, osteoarthritis, ... conventional treatment for pain management is dominated by opioid ...
(Date:3/30/2015)... March 19th, 2015, in the Hall of Legends at ... hosted the “Fighting Addiction Together” luncheon. Attendees included local ... as other civic leaders and public figures. , Several ... Detroit Lions wide receiver Herman Moore, Live to be ... own personal battles with addiction, Ronald Stevens and Jerri ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... addition of the "Computer Aided Detection (CAD) ... their offering. Annual estimates and forecasts ... Also, a six-year historic analysis is provided for ... from primary and secondary research. Company profiles are ...
(Date:3/30/2015)... WHITE PLAINS, N.Y. , March 30, 2015 /PRNewswire-USNewswire/ ... developing new treatments for patients with a rare and ... from a recent licensing agreement with a new biotechnology ... has been funding this work, led by Assistant Professor ... Tomasz Cierpicki , Ph.D., at the University of Michigan, ...
(Date:3/30/2015)... Research and Markets ( ... the "Urological Catheters - Global Strategic ... This report analyzes the worldwide ... and US$ Thousands by the following Product ... Catheters), and Urinary Catheters (Foley Catheters, Intermittent ...
Breaking Medicine Technology:Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 2Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 3Computer Aided Detection (CAD) - Global Strategic Business Report 2015-2020: Rising Incidence of Cancer - A Major Market Driver 4Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 2Leukemia Research Funded by The Leukemia & Lymphoma Society Gets Infusion of Support from Startup Biotechnology Company 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7
Cached News: